Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type

References

• Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissueLyon: IARC Press2001.
   Google Scholar
• Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996;87:1207–1210.
   PubMed Web of Science ®Google Scholar
• Oshimi K. Leukemia and lymphoma of natural killer lineage cells. Int J Hematol 2003;78:18–23.
   PubMed Web of Science ®Google Scholar
• Chen CY, Yao M, Tang JL, Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma. Ann Oncol 2004;15:1091–1096.
   PubMed Web of Science ®Google Scholar
• Au WY, Ma SY, Chim CS, Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol 2005;16:206–214.
   PubMed Web of Science ®Google Scholar
• Kwong YL, Chan AC, Liang R, CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997;97:821–829.
   PubMed Web of Science ®Google Scholar
• Li CC, Tien HF, Tang JL, Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004;100:366–375.
   PubMed Web of Science ®Google Scholar
• Chim CS, Ma SY, Au WY Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004;103:216–221.
   PubMed Web of Science ®Google Scholar
• Murashige N, Kami M, Kishi Y, Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005;130:561–567.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Suzumiya J, Nakamura S, Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006;37:425–431.
   PubMed Web of Science ®Google Scholar
• Takenaka K, Shinagawa K, Maeda Y, High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leuk Lymphoma 2001;42:1297–1303.
   PubMed Web of Science ®Google Scholar
• Makita M, Maeda Y, Takenaka K, Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions. Int J Hematol 2002;76:94–97.
   PubMed Web of Science ®Google Scholar
• Kako S, Izutsu K, Oshima K, Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Am J Hematol 2007;82:937–939.
   PubMed Web of Science ®Google Scholar
• Yagi T, Fujino H, Hirai M, Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer/T cell lymphoma, nasal type. Bone Marrow Transplant 2003;32:451–453.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Horning SJ, Coiffier B, Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Pfistner B, Juweid ME, Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, DeFor TE, Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003;102:1915–1919.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825–828.
   PubMed Web of Science ®Google Scholar
• Izutsu K, Kanda Y, Ohno H, Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. Blood 2004;103:1955–1960.
   PubMed Web of Science ®Google Scholar
• Kim SW, Tanimoto TE, Hirabayashi N, Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. Blood 2006;108:382–389.
   PubMed Web of Science ®Google Scholar
• Le Gouill S, Milpied N, Buzyn A, Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. J Clin Oncol 2008;26:2264–2271.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Yamada MF, Ishizawa K, Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation. Tohoku J Exp Med 2007;211:395–399.
   PubMed Web of Science ®Google Scholar
• Mori Y, Aoki T, Takenaka K, Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation. Int J Hematol 2010;91:107–111.
   PubMed Web of Science ®Google Scholar
• Lee J, Au WY, Park MJ, Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 2008;14:1356–1364.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Bang SM, Lee J, High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplant 2006;37:819–824.
   PubMed Web of Science ®Google Scholar
• Au WY, Lie AK, Liang R, Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value. Ann Oncol 2003;14:1673–1676.
   PubMed Web of Science ®Google Scholar
• Au WY, Pang A, Choy C, Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004;104:243–249.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Suzuki R, Kwong YL, Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016–1020.
   PubMed Web of Science ®Google Scholar
• Jaccard A, Petit B, Girault S, L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol 2009;20:110–116.
   PubMed Web of Science ®Google Scholar
• Kim BS, Kim DW, Im SA, Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Ann Oncol 2009;20:121–128.
   PubMed Web of Science ®Google Scholar